{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:55:00Z","timestamp":1767923700151,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.dmpk.2020.05.004","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T13:07:26Z","timestamp":1589980046000},"page":"389-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data"],"prefix":"10.1016","volume":"35","author":[{"given":"Keigo","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suemizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Mizunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-4261","authenticated-orcid":false,"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2020.05.004_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1124\/dmd.113.054031","article-title":"A\u00a0perspective on the prediction of drug pharmacokinetics and disposition in drug research and development","volume":"41","author":"Di","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.05.004_bib2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1124\/dmd.105.004143","article-title":"A\u00a0novel model for prediction of human drug clearance by allometric scaling","volume":"33","author":"Tang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.05.004_bib3","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.20650","article-title":"Prediction of human drug clearance from animal data: Application of the rule of exponents and \u201cfu Corrected Intercept Method\u201d (FCIM)","volume":"95","author":"Mahmood","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/0091270008320369","article-title":"Estimation of human drug clearance using multiexponential techniques","author":"Goteti","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2020.05.004_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/00498254.2016.1205761","article-title":"A\u00a0unified strategy in selection of the best allometric scaling methods to predict human clearance based on drug disposition pathway","author":"Liu","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib6","doi-asserted-by":"crossref","DOI":"10.1021\/js960440h","article-title":"Integration of in\u00a0vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs","author":"Lave","year":"1997","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfm041","article-title":"Humanization of excretory pathway in chimeric mice with humanized liver","author":"Okumura","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2017.11.001","article-title":"Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery","author":"Naritomi","year":"2018","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2020.05.004_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00498254.2015.1007112","article-title":"Predictability of plasma concentration\u2013time curves in humans using single-species allometric scaling of chimeric mice with humanized liver","volume":"45","author":"Sanoh","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib10","article-title":"Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver","volume":"1\u201312","author":"Miyamoto","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/00498254.2018.1460516","article-title":"Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver","author":"Nakayama","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib12","first-page":"1","article-title":"Predicting successful\/unsuccessful extrapolation for in\u00a0vivo total clearance of model compounds with a variety of hepatic intrinsic metabolism and protein bindings in humans from pharmacokinetic data using chimeric mice with humanised liver","author":"Sawada","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jps.21582","article-title":"On the prediction of hepatic clearance using the diluted plasma in metabolic stability assay","author":"Berezhkovskiy","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u201chumanized liver\u201d in TK-NOG mice is mature and functional","author":"Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dmpk.2020.05.004_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.111.040923","article-title":"Prediction of in\u00a0vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver","volume":"40","author":"Sanoh","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.05.004_bib16","doi-asserted-by":"crossref","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmpk.2020.05.004_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/00498254.2016.1199063","article-title":"Simulation of human plasma concentration\u2013time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite using humanized chimeric mice and semi-physiological pharmacokinetic modeling","author":"Kamimura","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2020.05.004_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/labinvest.2012.158","article-title":"Morphological and microarray analyses of human hepatocytes from xenogeneic host livers","author":"Tateno","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.dmpk.2020.05.004_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/19420862.2015.1008345","article-title":"Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs","volume":"7","author":"Roopenian","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.dmpk.2020.05.004_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2133\/dmpk.25.223","article-title":"Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites","volume":"25","author":"Kamimura","year":"2010","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2020.05.004_bib21","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.108.020479","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds","author":"Obach","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2020.05.004_bib22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/jps.20373","article-title":"Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: molecular properties associated with extrapolative success or failure","volume":"94","author":"Jolivette","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00561944","article-title":"Intravenous quinidine in congestive cardiomyopathy","volume":"19","author":"Ochs","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2020.05.004_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejps.2010.03.009","article-title":"Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability","volume":"40","author":"Lappin","year":"2010","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.dmpk.2020.05.004_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/clpt.1982.54","article-title":"The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses","author":"McAllister","year":"1982","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720303669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:54:58Z","timestamp":1761162898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436720303669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1347436720303669"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.05.004","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}